We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+5.61%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$375M
AUM Growth
+$5.98M
Cap. Flow
-$10.7M
Cap. Flow %
-2.85%
Top 10 Hldgs %
17.55%
Holding
221
New
23
Increased
111
Reduced
62
Closed
17

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$6.47M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
+$4.68M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$2.92M
4
CYBR
CyberArk
CYBR
+$2.32M
5
SANM icon
Sanmina
SANM
+$1.37M

Top Sells

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$10.2M
2
INGR icon
Ingredion
INGR
+$8.28M
3
MDU icon
MDU Resources
MDU
+$8.08M
4
DIS icon
Walt Disney
DIS
+$6.24M
5
SUPN icon
Supernus Pharmaceuticals
SUPN
+$5.34M

Sector Composition

Rank Sector Weight
1 Healthcare 17.78%
2 Technology 15.38%
3 Industrials 12.46%
4 Consumer Staples 9.28%
5 Materials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QLYS icon
1
Qualys
QLYS
$5.61B
$7.65M 2.04%
147,683
+4,926
+3% +$226K
PANW icon
2
Palo Alto Networks
PANW
$292B
$6.99M 1.87%
291,216
-449,772
-61% -$10.2M
BMRN icon
3
BioMarin Pharmaceuticals
BMRN
$11.5B
$6.82M 1.82%
+73,226
New +$6.47M
FMC icon
4
FMC
FMC
$1.4B
$6.58M 1.76%
84,890
+3,473
+4% +$249K
PYPL icon
5
PayPal
PYPL
$49.9B
$6.54M 1.75%
102,135
+1,209
+1% +$72.4K
ATVI
6
DELISTED
Activision Blizzard
ATVI
$6.47M 1.73%
100,266
+2,552
+3% +$159K
TIF
7
DELISTED
Tiffany & Co.
TIF
$6.42M 1.72%
70,000
-2,500
-3% -$229K
TRMB icon
8
Trimble
TRMB
$12.3B
$6.25M 1.67%
159,316
+5,214
+3% +$198K
CW icon
9
Curtiss-Wright
CW
$26.1B
$6.22M 1.66%
59,476
+3,279
+6% +$318K
KSU
10
DELISTED
Kansas City Southern
KSU
$5.81M 1.55%
53,450
+3,344
+7% +$351K
DAR icon
11
Darling Ingredients
DAR
$10B
$5.79M 1.55%
330,589
-10,235
-3% -$173K
GRA
12
DELISTED
W.R. Grace & Co.
GRA
$5.62M 1.5%
77,912
+6,983
+10% +$493K
TMO icon
13
Thermo Fisher Scientific
TMO
$198B
$5.54M 1.48%
29,270
+1,815
+7% +$329K
ACAD icon
14
Acadia Pharmaceuticals
ACAD
$4.38B
$5.42M 1.45%
+143,876
New +$4.68M
FUL icon
15
H.B. Fuller
FUL
$3.06B
$5.11M 1.36%
87,964
+9,592
+12% +$502K
ST icon
16
Sensata Technologies
ST
$6.55B
$5.06M 1.35%
105,246
+9,896
+10% +$447K
INGR icon
17
Ingredion
INGR
$6.47B
$4.98M 1.33%
41,287
-67,880
-62% -$8.28M
MDU icon
18
MDU Resources
MDU
$4.42B
$4.93M 1.32%
499,589
-809,473
-62% -$8.08M
TEN
19
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$4.9M 1.31%
80,814
+10,251
+15% +$576K
CSL icon
20
Carlisle Companies
CSL
$14B
$4.84M 1.29%
48,310
+4,022
+9% +$390K
BALL icon
21
Ball Corp
BALL
$16.7B
$4.76M 1.27%
115,379
+4,051
+4% +$166K
LH icon
22
Labcorp
LH
$23.2B
$4.73M 1.26%
36,494
+3,310
+10% +$441K
AVNT icon
23
Avient
AVNT
$3.39B
$4.68M 1.25%
116,829
+11,296
+11% +$421K
FBIN icon
24
Fortune Brands Innovations
FBIN
$6.14B
$4.62M 1.23%
80,323
+2,558
+3% +$142K
TSCO icon
25
Tractor Supply
TSCO
$16B
$4.44M 1.19%
350,790
+47,860
+16% +$543K
1
2 3 4 5

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $812M AUM 17.34% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return

Stanley-Laman Group's Q3 2017 Portfolio in Review

As of Q3 2017, Stanley-Laman Group held 221 positions worth $375M, up 1.6% from $369M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Stanley-Laman Group's Q3 2017 filing shows 23 new, 111 increased, 62 reduced and 17 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 73,226 shares worth $6.82M. The largest sale was Palo Alto Networks, an estimated $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Stanley-Laman Group's largest Q3 2017 buy was BioMarin Pharmaceuticals: 73,226 shares worth $6.82M.
  • Stanley-Laman Group added most to Zix Corporation in Q3 2017, an estimated $1.31M increase.
  • Stanley-Laman Group's biggest Q3 2017 reduction was Palo Alto Networks, cutting an estimated $10.2M.
  • Stanley-Laman Group fully exited Supernus Pharmaceuticals in Q3 2017, selling an estimated $5.34M.
  • Stanley-Laman Group's ten largest holdings make up 18% of its $375M portfolio in Q3 2017.
  • Stanley-Laman Group opened 23 new positions and closed 17 in Q3 2017.
  • Stanley-Laman Group's portfolio value rose 1.6% quarter-over-quarter to $375M.

Based on Stanley-Laman Group's 13F filing for Q3 2017, filed 13 Nov 2017.